medullipin I (ANRL)

vasodepressor lipid extracted from renal papilla, renomedullary cells grown in monolayer culture & renal venous effluent after uncliping Goldblatt hypertensive rat

Also Known As:

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Atherosclerosis 12/01/1990 - "Nine possible roles are traced by which surface-active phospholipid could impinge upon neurogenic control of blood pressure, the effects of circulating relaxing factors, blood rheology, atherosclerosis, and the major renal aspects of control by diuresis and association with the antihypertensive neutral renomedullary lipid. "
2.	Renovascular Hypertension (Goldblatt Syndrome) 04/01/1991 - "Medullipin I and II and maybe platelet activating factor (PAF), seem to be the mediators of this system, known to be activated after reversal of renovascular hypertension or when the perfusion pressure to a normotensive kidney is suddenly elevated. "
3.	Renal Hypertension 04/01/1991 - "Furthermore, all mean arterial pressure reductions caused by high-pressure perfusion of Wistar Kyoto and spontaneously hypertensive rat kidneys were accompanied by reductions in heart rate (HR) in the 'donors', in agreement with previous observations after reversing renal hypertension and after i.v. medullipin I injection. "

Related Drugs and Biologics

1.	Platelet Activating Factor
2.	Phospholipids (Phosphatides)